SG Americas Securities
RNA

SG Americas Securities’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

SG Americas Securities’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-149,123
Closed -$2.8M – 3419
2014
Q4 		$2.8M Buy
+149,123
New +$2.12M 0.01% 842

SG Americas Securities's RNA Position: Q1 2015 in Review

SG Americas Securities sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q1 2015, closing a stake of 149,123 shares — an estimated $2.8M sold.

SG Americas Securities first reported a position in RNA in Q4 2014 and held it in 1 quarter. The position peaked at $2.8M in Q4 2014. 0 funds tracked by Wall St. Rank hold RNA as of Q1 2015.

  • SG Americas Securities reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q1 2015 after selling out during the quarter.
  • SG Americas Securities sold 149,123 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q1 2015, an estimated $2.8M.
  • SG Americas Securities first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q4 2014 and held it in 1 quarter.
  • SG Americas Securities's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $2.8M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q1 2015.

Based on SG Americas Securities's 13F filing for Q1 2015, filed 13 May 2015.